Fruquintinib Combined With Standard Chemotherapy Versus Standard Chemotherapy as First-line Treatment for Advanced pMMR Endometrial Cancer

Clinical trial NCT07170982 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07170982
Sponsor: Sun Yat-sen University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Endometrial Cancer

Start date: 2025-10-15
Primary completion: 2027-10-15
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.